New Roche, Versant venture targets multiple sclerosis

Drug maker Roche and venture capital firm Versant Ventures started a new company focused on regrowing the protective sheaths around nerve cells in multiple sclerosis patients...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.